On this page

AFREZZA

Insulin Human · Kit

Prescription Biologic BLA
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information.

Overview

Brand name
AFREZZA
Generic name
Insulin Human
Dosage form
Kit
Route
Respiratory (Inhalation)
Marketing category
BLA · BLA
Labeler
Mannkind Corporation
Product type
Human Prescription Drug
DEA schedule
Not scheduled
Active ingredients
0
NDC product codes
4
Packages
4
Data completeness
52% of corroborating sources present

Forms, strengths and routes

Source: NDC Directory
Dosage form
Kit
Route of administration
Respiratory (Inhalation)
Presentations
8

Regulatory status

Source: Drugs@FDANDC Directory
Application number
022472
Application type
BLA · Biologics License Application
Approval date
June 27, 2014
Sponsor
MANNKIND
Products on application
3
Submissions recorded
15
Products approved under application 022472.
Product Trade name Form Strength Ingredient Status TE Flags
022472-001 AFREZZA POWDER INSULIN RECOMBINANT HUMAN Prescription —
022472-002 AFREZZA POWDER INSULIN RECOMBINANT HUMAN Prescription —
022472-003 AFREZZA POWDER INSULIN RECOMBINANT HUMAN Prescription —

Approval history

Source: Drugs@FDA
Most recent submissions on application 022472.
Type No. Action Status Date Review
Supplement 29 Efficacy Approved May 29, 2026 Standard
Supplement 27 Efficacy Approved January 23, 2026 Standard
Supplement 23 Labeling Approved February 3, 2023 Standard
Supplement 18 Labeling Approved October 25, 2018 Standard
Supplement 17 REMS Approved April 24, 2018 N/A
Supplement 11 Efficacy Approved September 29, 2017 Standard
Supplement 10 Manufacturing (CMC) Approved April 7, 2016 Standard
Supplement 9 Manufacturing (CMC) Approved February 17, 2016 Standard
Supplement 4 Manufacturing (CMC) Approved September 16, 2015 N/A
Supplement 8 Labeling Approved June 24, 2015 Standard
Supplement 6 Manufacturing (CMC) Approved June 24, 2015 Standard
Supplement 2 REMS Approved April 20, 2015 N/A
Supplement 3 Manufacturing (CMC) Approved April 17, 2015 Standard
Supplement 5 Labeling Approved March 12, 2015 Standard
Original application 1 Type 5 - New Formulation or New Manufacturer Approved June 27, 2014 Standard

Review documents

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
47918-880-18 47918-880 Mannkind Corporation 1 KIT in 1 CARTON (47918-880-18) * 3 POUCH in 1 PACKAGE, COMBINATION / 2 BLISTER PACK in 1 POUCH / 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE * 3 POUCH in 1 PACKAGE, COMBINATION / 2 BLISTER PACK in 1 POUCH / 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE July 1, 2016
47918-898-18 47918-898 Mannkind Corporation 1 KIT in 1 CARTON (47918-898-18) * 3 POUCH in 1 PACKAGE, COMBINATION / 2 BLISTER PACK in 1 POUCH / 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE * 3 POUCH in 1 PACKAGE, COMBINATION / 2 BLISTER PACK in 1 POUCH / 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE December 4, 2018
47918-902-18 47918-902 Mannkind Corporation 1 KIT in 1 CARTON (47918-902-18) * 2 POUCH in 1 PACKAGE, COMBINATION / 2 BLISTER PACK in 1 POUCH / 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE * 2 POUCH in 1 PACKAGE, COMBINATION / 2 BLISTER PACK in 1 POUCH / 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE * 2 POUCH in 1 PACKAGE, COMBINATION / 2 BLISTER PACK in 1 POUCH / 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE January 10, 2017
47918-904-30 47918-904 Mannkind Corporation 1 KIT in 1 CARTON (47918-904-30) * 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE * 15 CARTRIDGE in 1 BLISTER PACK / 1 POWDER, METERED in 1 CARTRIDGE June 1, 2025
47918-880 47918-880 Mannkind Corporation — July 1, 2016
47918-898 47918-898 Mannkind Corporation — December 4, 2018
47918-902 47918-902 Mannkind Corporation — January 10, 2017
47918-904 47918-904 Mannkind Corporation — June 1, 2025

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Purple Book FDA Biologic licence classification

Generated September 25, 2026 · 7 sections on this page.